Latest Manufacturing News

Argent BioPharma has eliminated US$5.5 million in secured debt through a global licensing agreement for its CannEpil® epilepsy therapy, while completing a key acquisition and advancing clinical trials in veterinary therapeutics.

EVZ Limited closed FY26 with a net positive operating cash flow of $10.1 million and an $18.3 million cash balance, while maintaining a robust $80 million contract backlog and progressing several acquisition opportunities for FY27.

RLF AgTech posted a seasonally strong June quarter with $7.1 million in cash receipts, driven by record pre-season payments in China and tight cost control that brought operating cash flow close to breakeven.

Australian Strategic Materials (ASM) has announced a revised timetable for its shareholder scheme meetings tied to Energy Fuels’ acquisition, alongside dispatching a supplementary booklet that updates key transaction details including a new expert report. The acquisition now contemplates Energy Fuels’ conditional US$725 million financing and a US$1.9 billion deal to acquire VAC.

Clean TeQ Water has marked a milestone with its inaugural recurring revenue from ATA® technology and a 45% jump in quarterly customer receipts, underpinned by contract wins and project progress across global water and critical minerals markets.

Arovella Therapeutics secured ethics approval and manufactured its first clinical batch of ALA-101, targeting blood cancers, while progressing its solid tumour program and refining autoimmune strategies. The company ended the quarter with $14.4 million in cash, supporting imminent clinical milestones.

Lumos Diagnostics reported a 6% revenue increase to US$13.2 million for FY26, driven by an 875% surge in FebriDx® sales following a pivotal CLIA waiver. The company expanded U.S. adoption to 170+ healthcare sites and secured milestone payments exceeding US$6 million.

Canadian Phosphate (ASX: CP8) has kicked off a 3,000-metre drilling campaign at its Wapiti Phosphate Project in British Columbia, aiming for a Mineral Resource Estimate by late 2026 that will support both traditional fertilizer and advanced battery material markets.

Imugene's azer-cel therapy shows a third patient response in the BTKi combination cohort of its Phase 1b trial, while CEO Leslie Chong steps down after nearly 11 years, prompting a leadership search.

Noronex Ltd has secured a major foothold in the US critical minerals sector by acquiring the Sleitat Tin-Tungsten-Silver Project in Alaska, featuring a substantial historic tin estimate and promising exploration upside.

Biome Australia (ASX: BIO) edged close to breakeven in FY26, driven by $1.8 million in international sales across four markets and a 68% gross margin. The company is set to launch onshore manufacturing and a digital health platform to accelerate growth.

Critical Resources (ASX:CRR) spotlighted its multi-commodity pipeline and breakthrough battery cooling technology at the July 2026 TechKnow Invest Roadshow, highlighting exploration progress and exclusive global licensing deals.